| __timestamp | Ligand Pharmaceuticals Incorporated | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 5280000 |
| Thursday, January 1, 2015 | 13380000 | 7148000 |
| Friday, January 1, 2016 | 21221000 | 19594000 |
| Sunday, January 1, 2017 | 26887000 | 22894000 |
| Monday, January 1, 2018 | 27863000 | 50337000 |
| Tuesday, January 1, 2019 | 55908000 | 109450000 |
| Wednesday, January 1, 2020 | 59392000 | 90450000 |
| Friday, January 1, 2021 | 69012000 | 104128000 |
| Saturday, January 1, 2022 | 36082000 | 108630000 |
| Sunday, January 1, 2023 | 24537000 | 134951000 |
Data in motion
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Rhythm Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated have demonstrated contrasting approaches to research and development (R&D) spending. From 2014 to 2023, Rhythm Pharmaceuticals increased its R&D expenses by an impressive 2,455%, peaking in 2023. In contrast, Ligand Pharmaceuticals saw a more modest growth of 102% over the same period, with its highest expenditure in 2021. This divergence highlights Rhythm's aggressive investment in innovation, potentially positioning it for breakthroughs in the coming years. Meanwhile, Ligand's steadier approach may reflect a focus on optimizing existing assets. As the pharmaceutical landscape evolves, these spending patterns could significantly impact each company's future success.
Analyzing R&D Budgets: AbbVie Inc. vs Rhythm Pharmaceuticals, Inc.
GSK plc vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
United Therapeutics Corporation or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Insmed Incorporated vs Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ligand Pharmaceuticals Incorporated
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and Rhythm Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and MorphoSys AG